The TARC/sICAM5 Ratio in Patient Plasma is a Candidate Biomarker for Drug Resistant Epilepsy

Overview of attention for article published in Frontiers in Neurology, January 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 1 X user

patent: 3 patents

Citations

dimensions_citation: 47 Dimensions

Readers on

mendeley: 69 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Biomarkers and methods for detection of seizures and epilepsy

Grant US-11598782-B2

United States of America

BIOMARKERS AND METHODS FOR DETECTION OF SEIZURES AND EPILEPSY

Application EP-3624826-A4

European Patent Office

BIOMARKERS AND METHODS FOR DETECTION OF SEIZURES AND EPILEPSY

Application EP-3399997-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.